Page last updated: 2024-09-03

u 86983 and 9-(2-hydroxy-3-nonyl)adenine

u 86983 has been researched along with 9-(2-hydroxy-3-nonyl)adenine in 1 studies

Compound Research Comparison

Studies (u 86983)	Trials (u 86983)	Recent Studies (post-2010) (u 86983)	Studies (9-(2-hydroxy-3-nonyl)adenine)	Trials (9-(2-hydroxy-3-nonyl)adenine)	Recent Studies (post-2010) (9-(2-hydroxy-3-nonyl)adenine)
6	0	0	30	0	11

Protein Interaction Comparison

Protein	Taxonomy	u 86983 (IC50)	9-(2-hydroxy-3-nonyl)adenine (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesterase	Homo sapiens (human)		2.145

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbott, BM; Thompson, PE	1

Other Studies

1 other study(ies) available for u 86983 and 9-(2-hydroxy-3-nonyl)adenine

Article	Year
PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues. Bioorganic & medicinal chemistry letters, 2004, Jun-07, Volume: 14, Issue:11 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Chromones; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Morpholines; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship	2004

Article

Year

PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues.

Bioorganic & medicinal chemistry letters, 2004, Jun-07, Volume: 14, Issue:11

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Chromones; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Morpholines; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2004